Corevalve Evolut Promotes Sealing Between Prosthetic Native Valves
The Medtronic CoreValve Evolut 23 mm valve is the latest self-expanding transcatheter aortic valve implantation (TAVI) system from Medtronic Inc. The new valve incorporates technology that optimizes fit, thereby promoting sealing between the prosthetic valve and the native valve (TruFit Technology). The Medtronic CoreValve System is currently limited to investigational use in the United States.
With the introduction of the CoreValve Evolut valve, Medtronic can now treat the broadest range of TAVI patient valve sizes (annulus diameters from 18 mm to 29 mm).
Medtronic now offers TAVI in four valve sizes (23 mm, 26 mm, 29 mm and 31 mm), each deliverable via transfemoral, subclavian and direct aortic access through a low-profile, 18 French delivery catheter.
The catheter received CE mark in September 2012.
For more information: www.medtronic.com